In patients with Rutherford 1 ALI, how does systemic anticoagulation compare to revascularisation in terms of long-term outcomes?

No direct evidence for long-term outcomes of systemic anticoagulation versus revascularization in Rutherford 1 ALI was identified. Evidence from broader contexts suggests revascularization offers potential benefits in severe ischemia, but further research is needed for less severe cases.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-10-30
DOI
https://doi.org/10.5281/zenodo.23811186
Primary Topic
Peripheral Artery Disease Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

In patients with Rutherford 1 ALI, how does systemic anticoagulation compare to revascularisation in terms of long-term outcomes?

Tripdatabase
1 links
Zenodo (CERN European Organization for Nuclear Research)
Peripheral Artery Disease Management
article

In patients with Rutherford 1 ALI, how does systemic anticoagulation compare to revascularisation in terms of long-term outcomes?

Tripdatabase
article en

Abstract

No direct evidence for long-term outcomes of systemic anticoagulation versus revascularization in Rutherford 1 ALI was identified. Evidence from broader contexts suggests revascularization offers potential benefits in severe ischemia, but further research is needed for less severe cases.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 10%
Peripheral Artery Disease Management
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
In patients with Rutherford 1 ALI, how does systemic anticoagulation compare to revascularisation in terms of long-term outcomes? — Tripdatabase · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS